Quality of life in gynecologic cancer survivors compared to healthy check-up women by Wilailak, Sarikapan et al.
INTRODUCTION
In the modern management of cancer, apart from treating 
the disease, psychological and social aspects of the patients 
should be taken into account in order to achieve the highest 
quality of life (QoL). Being subjective and multidimensional, 
QoL is defined as “the extent to which one’s usual or expected 
physical, emotional and social well-being as affected by a 
medical condition or its treatment” [1]. There are several 
dimensions ranging from physical concerns to cognitive 
functioning [2]. Questionnaires have been widely used and 
accepted as the standard tool because the results can be 
compared among studies.
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Objective: The primary objective of this study was to compare quality of life of disease-free patients after therapy for 
gynecologic malignancies at follow-up in comparison with healthy check-up patients. Our second objective was to assess 
correlation between demographic data, disease and treatment factors and quality of life scores.
Methods: Patients completed the Functional Assessment of Cancer Therapy-General (FACT-G) quality of life questionnaire at 
least 6 months after treatment for a gynecologic malignancy. Responses were compared to unmatched healthy women who 
were seen for standard gynecologic screening examinations. Statistical calculation was done using chi-squared tests, Wilcoxon 
rank-sum, and Kruskal-Wallis one-way analysis and Spearman rank correlations. Factors associated with FACT-G scores were 
evaluated using univariate and multivariate analyses.
Results: Eight hundred and seventy patients were recruited. The median time since therapy was 61 months (range, 6 to 173 
months). The overall FACT-G scores were higher in the patient group than in the healthy group (p<0.05). The scores of each 
subscale measuring physical, functional, social/family and emotional well-being were also higher in the patient group (p<0.05). 
Multivariate analysis revealed correlation between Eastern Cooperative Oncology Group performance status, educational level, 
care giver, presence of economic problems and FACT-G scores.
Conclusion: The quality of life scores were higher in gynecologic cancer patients after treatment. And the factors that associated 
with the higher score in the patient group are having husband as a caregiver, no financial problem, Eastern Cooperative 
Oncology Group score 0 or 1 and having high school or higher education.
Keywords: Quality of life, Functional Assessment of Cancer Therapy-General, Gynecologic cancer
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is a QoL questionnaire developed by Cella et al. [3] from 
Northwestern University. The fourth version of FACT-G 
includes a 27-item core questionnaire that evaluates 4 
aspects of the patients’ well-being i.e., physical, social/family, 
emotional, and functional status. This questionnaire has been 
accepted worldwide. It was translated into the Thai version by 
Ratanatharathorn et al. [4] and was tested and proven to be 
reliable and valid.
While there have been many studies on QoL among 
cancer patients during treatment [5], few have addressed 
QoL after treatment, especially in the out-patient settings. 
The importance of QoL is one of the patient measurement 
outcomes of patients under the diversity of treatment 
options. In the recovery period after intense treatment, 
the impact on QoL may be prolonged. The information 
from these recovering gynecologic cancer patients is 
interesting especially in comparison to healthy women. 
Thus the first objective of this study was to compare quality 
of life of disease-free patients after therapy for gynecologic 
malignancies at follow-up in comparison with healthy check-
up women. Our second objective was to assess correlation 
between demographic data, disease and treatment factors 
and QoL scores.
MATERIALS AND METHODS
1. Participant selection and eligibility
Using a cross-sectional design, this study investigated two 
groups of participants: the study and the control groups. The 
study group consisted of gynecologic malignancy patients 
who came for follow-up at the Gynecologic Oncology 
Clinic, Department of Obstetrics and Gynecology, Faculty of 
Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 
Thailand. Eligibility criteria included more than 6 months from 
completion of treatment for a gynecologic malignancy, no 
recurrence of disease, full consciousness, ability to understand 
and communicate in Thai, and consent to participate in the 
study. Patients with psychiatric disorders, communication 
disorders, severe medical condition or coexisting malignancies 
were excluded.
The control group consisted of healthy women who were 
seen for standard gynecologic screening exams at General 
Gynecology Clinic and who had ability to understand and 
communicate in Thai, and consent to participate in the study. 
The study protocol was approved by the institutional Ethics 
Committee (July, 2004) and written informed consents were 
obtained from all patients. 
2. Quality of life measures
After having been recruited according to the inclusion 
and exclusion criteria, the patients were given information 
sheets explaining backgrounds, objectives, benefits and 
confidentiality of the study and, thereafter, the patients gave 
their consents. Each participant were asked to complete 
two sets of questionnaires, one was a general personal 
questionnaire inquiring about their marital status, educational 
level, occupations, care givers, methods of payment for 
therapy, financial status and other coexisting medical 
conditions, the other was the fourth version of Functional 
Assessment of Cancer Therapy-General (FACT-G) QoL 
questionnaire. The FACT-G includes four subscales measuring 
physical (PWB), social/family (SFWB), emotional (EWB), and 
functional well-being (FWB). Each subscale had its own score 
and all contributed to the overall FACT-G score. The higher 
scores mean better QoL. Participants were asked to rate how 
they felt on that day and the past 7 days.
The answered questionnaires were then reviewed and 
verified with the participants. Unanswered questions were 
repeated verbally, and in case the participants were unwilling 
to answer those questions, the investigators would probe for 
their reasons.
Data regarding type of malignancy, stage of disease, mode 
of treatment, treatment duration and interval, performance 
status, hormonal therapy and recurrence status were 
extracted from the medical records by the investigators.
3. Statistical analysis
Statistical analyses were performed using SPSS ver. 11.5 
(SPSS Inc., Chicago, IL, USA). In univariate analysis, chi-squared 
tests, Wilcoxon rank-sum, and Kruskal-Wallis one-way analysis 
were used to compare between categorical and continuous 
data. Spearman rank correlations were used for multivariate 
analysis, p<0.05 were taken as significant.
RESULTS
Between January, 2005-December, 2008, eight hundred 
and seventy gynecological cancer patients completed the 
questionnaire. Ten patients were unwilling to answer the 
questionnaire. From 440 unmatched healthy women, 399 
completed the questionnaire. According to the participants, 
the reasons for not having answered were a lack of time and 
inconvenience.
With regard to the patient characteristics (Table 1), gyne  co-
lo  gic cancer patients were divided into those with cervical 
can  cer (n=571, 65.6%), ovarian cancer (n=149, 17.1%), endo-Quality of life of gynecologic cancer patients
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metrial cancer (n=108, 12.4%), uterine sarcoma (n=15, 1.7%), 
gestational trophoblastic neoplasia (n=22, 2.5%), vulvar cancer 
(n=3, 0.3%) and vaginal cancer (n=2, 0.2%). Prior modalities 
of treatment included surgery alone (28.7%), radiation alone 
(34.4%), chemotherapy alone (1.4%) and combination therapy 
(35.5%). Most patients had treatment time of less than 2 mon-
ths (66.9%). Time since completion of treatment was more 
than 60 months in 50.2% of patients, with median time of 
61 months (range, 6 to 173 months). The characteristics of 
Table 1. Characteristics of patients and control group
 
Cancer 
patients  
(n=870)
Healthy 
women  
(n=399)
p-value*
Cancer site 
  Cervical cancer  571 (65.6) -
  Ovarian cancer  149 (17.1) -
  Endometrial cancer  108 (12.4) -
  Uterine sarcoma  15 (1.7) -
  Gestational trophoblastic
    neoplasia
22 (2.5) -
  Vulva cancer     3 (0.3) -
  Vaginal cancer     2 (0.2) -
Median age (yr) 53.4 42.7 <0.001
Marital status     <0.001
  Single 103 (11.8)   46 (11.6)  
  Married 523 (60.1) 308 (77.3)  
  Divorced/separated 254 (28.1)   45 (11.1)  
Education   <0.001
  <High school 524 (60.2) 154 (38.6)  
  High school 219 (25.2) 127 (31.8)  
  College 127 (14.6) 118 (29.6)  
Employment     <0.001
  Employed 567 (65.2) 342 (85.7)  
  Housewife (unemployed) 303 (34.8)   57 (14.3)  
Living   0.042
  Live with family/friend 804 (92.4) 354 (88.7)  
  Live alone 66 (7.6)   45 (11.3)  
Principal caregivers     <0.001
  Husband 296 (34.0) 253 (63.3)  
  Relatives 475 (54.6)   87 (21.8)  
  None    99 (11.4)   59 (14.6)  
Financial   0.844
  Financial difficulties 311 (35.7) 140 (35.1)  
  No financial difficulties 559 (64.3) 259 (64.9)  
ECOG performance status     <0.001
  0 219 (25.2) 221 (55.4)  
  1 655 (52.3) 153 (38.3)  
  2 196 (22.5) 25 (6.3)  
Values are presented as number (%).
ECOG, Eastern Cooperative Oncology Group.
*Chi-square test.
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Table 3. Functional Assessment of Cancer Therapy-General (FACT-G) scores in gynecologic cancer patients
Variables No.
PWB SFWB EWB FWB Overall  FACT-G
Mean (SD) p-value Mean (SD) p-value Mean (SD) p-value Mean (SD) p-value Mean (SD) p-value
Type of cancer      0.059*      0.516*      0.1148*     0.254*    0.118*
  Cervical cancer 571 23.97  (4.20)   19.58  (5.37) 19.47  (3.64)   20.78  (5.29) 83.56 (13.58)  
  Ovarian cancer 149 24.28  (4.07)   20.03  (5.20) 19.60  (3.45)   21.62  (4.74) 85.23 (13.29)  
  Uterine cancer 123 25.47  (2.64)   21.54  (4.12)  21.00  (2.95)   21.93  (4.67) 85.45 (12.43)  
  Other cancer   27 24.86  (3.20)   19.53  (5.12) 20.12  (3.20)   21.24  (4.98) 87.26 (10.07)  
Mode of treatment                      
  Surgery      0.012
†      0.052
†    0.478
†      0.096
†    0.037
†
    Surgery 517 24.46  (3.72)    20.02 (18.52) 19.69  (3.44)   21.25  (4.91) 85.17 (12.55)  
    No surgery 353 23.79  (4.14)    19.19 (19.49)   19.52  (3.69)   20.66  (5.46)   83.01 (14.01)  
  Radiation    0.01
†      0.117
†       0.9335
†      0.046
†    0.033
†
    Radiation 510 23.90  (4.02)   19.40  (5.36) 19.61  (3.59)   20.72  (5.36) 83.44 (13.53)  
    No radiation 360 24.59  (3.71)   20.07  (5.16) 19.63  (3.48)   21.43  (4.80) 85.52 (12.80)  
  Chemotherapy      0.51
†   0.4196
†      0.819
†      0.104
†      0.018
†
    Chemotherapy 187 24.35  (3.90)   20.00  (5.30) 19.67  (3.44)   21.56  (4.85) 84.65 (13.51)  
    No chemotherapy 683 24.14  (3.91)   19.59  (5.28)   19.61  (3.57)   20.87  (5.22)   84.15 (13.21)  
  Combination      0.697
†      0.157
†    0.651
†      0.476
†  0.27
†
    Combination 309 24.26  (3.83)   20.08  (5.16) 19.69  (3.45)   21.18  (5.03) 84.77 (12.88)  
    Single 561 24.15  (3.95)   19.46  (5.34) 19.58  (3.59)   20.92  (5.21) 84.01 (13.36)  
Duration of treatment (mo)      0.244*      0.075*      0.391*      0.046*     0.054*
    < 2  582 24.18  (3.96)   19.31  (5.39) 19.54  (3.55)    20.77  (5.28) 83.46 (13.15)  
    2-4  181 23.86  (3.88)   20.59  (4.98) 19.55  (3.53)   21.07  (4.92) 85.03 (12.29)  
    4-6    60 24.95  (3.39)   20.39  (4.46) 20.17  (3.51)   22.00  (4.48) 87.81  (9.91)  
    > 6    47 24.62  (3.86)   19.83  (5.75)   20.19  (3.45)   22.60  (4.83)   86.79 (14.09)  
Time after treatment (mo)      0.809*        0.0003*      0.763*      0.762*     0.032*
  < 24  177 24.19  (3.65)   21.53  (4.10) 19.61  (3.49)   21.47  (5.03) 87.10 (12.02)  
  24-36 97 24.29  (3.32)   19.34  (5.19) 19.41  (3.82)   21.02  (5.56) 83.93 (18.85)  
  37-48  100 24.60  (3.88)   19.14  (5.16) 19.57  (3.45)   20.82  (5.17) 83.49 (13.04)  
  49-60    59 24.20  (3.71)   19.02  (5.32) 19.17  (3.56)   20.86  (4.63) 82.89 (12.58)  
  > 60 437 24.07  (4.16)   19.18  (5.62)   19.76  (3.52)   20.89  (5.17)   83.52 (13.74)  
ECOG performance   <0.001*   <0.001*      0.0001*   <0.001* <0.001*
  0 219 23.91  (4.22)    19.44 (5.50) 19.47  (3.53)   21.50  (5.29) 83.70 (13.38)  
  1 453 22.85  (4.38)    19.12 (5.42) 18.99  (4.05)   20.37  (5.35) 80.64 (14.31)  
  2 198 21.71  (4.73)    18.21 (5.14) 18.21  (4.39)   18.90  (5.41) 76.84 (14.31)  
Level of education        0.027*   <0.001*        0.0662*   <0.001*   <0.001*
  <high school 524 23.90  (4.01)   18.94  (5.43) 19.70  (3.50)   20.51  (5.53) 82.47 (13.62)  
  High school 219 24.50  (3.80)   20.31  (4.84) 19.39  (3.52)   21.20  (4.64) 85.36 (12.31)  
  College 126 24.79  (3.54)   21.62  (5.26)   19.92  (3.64)   23.02  (4.06)   88.45 (12.29)  
Age (yr)      0.107*   <0.001* <0.001*     0.003*   0.001*
  <40 117 24.13  (3.54)   19.59  (5.02) 18.51  (3.80)      21.68  (4.35) 81.08 (12.15)  
  40-60 507 24.40  (3.85)   19.89  (5.37) 19.77  (3.33)   21.53  (5.02) 85.43 (13.14)  
  >60 246 22.76  (4.17)   19.67  (5.03) 19.79  (3.79)   19.74  (5.63) 82.13 (14.02)  
Caregivers       0.096
†   <0.001
†      0.288
†      0.033
†      0.005
†
  Other  485 23.99  (4.61) 18.25  (5.12) 19.67  (4.08)   20.54  (5.27) 80.49 (13.23)  
  Husband  385 24.43  (3.76)   20.94  (5.10)   19.57  (3.51)   21.60  (4.91)   84.16 (12.07)  
Financial difficulties     <0.001
†      0.161
†         0.4207
†      0.421
†      0.025
†
  No 599 24.62  (3.78)   20.53  (5.04) 20.03  (3.39)   21.57  (5.04) 86.56 (12.80)  
  Yes 311 23.40  (4.01)   18.24  (5.64) 18.94  (3.65)   19.92  (5.15) 80.05 (13.09)  
PWB, physical well-being; SFWB, social/family well-being; EWB, emotional well-being; FWB, functional well-being; SD, stand deviation; Other cancers, gestational/
fophoblastic neoplasia, ualua cancer, uaginal cancer. 
*Kruskal-Wallis one-way analysis. 
†Wilcoxon rank-sum test.Quality of life of gynecologic cancer patients
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both cases and controls are also summarized in Table 1. The 
median age of the cancer patients was 53.42 years (range, 17 
to 82 years), while the median age was 42.71 years (range, 
20 to 69 years) in the healthy group. The majority of both 
groups were married, with higher proportion of divorce or 
se  paration in the cancer group (28.1% vs. 11.1%). Regarding 
the level of education, 52.3% patients in the cancer group 
fi  ni  shed primary school and 14.6% finished college, while 
35.8% and 29.6% of the healthy group finished primary 
school and college, respectively. Of patients in cancer group, 
34.8% were unemployed (housewives) compared to 14.3% in 
healthy group. Most of the participants stayed with their fa-
milies, and husbands and relatives were principal caregivers. 
However, the proportion of husbands as principal caregivers 
was different in the two groups (34.0% for cancer patient vs. 
63.3%). There were no significant differences between self- 
per  ceptions of financial difficulties between the two groups (in 
Thailand, the government provides support for basic health 
pro  blems, including cancer). The majority of cancer patients 
had Eastern Cooperative Oncology Group (ECOG) score 
performance status of 1 (52.3%) while the ma  jority of healthy 
women had ECOG score of 0 (55.4%).
In Table 2, the mean overall FACT-G score in the gynecologic 
cancer patient group was 82.15 (standard deviation 
[SD]=12.86), which was significantly higher than the healthy 
group (72.58, SD=13.80, p<0.05). The scores of each subscale 
measuring physical, functional, social/family and emotional 
well-being were also higher in the gynecologic cancer patient 
group than in the healthy group (p<0.05). The data of FACT-G 
scores in gynecologic cancer patients are demonstrated in 
Table 3. In the group of gynecologic cancer patients, factors 
that correlated with QoL scores in univariate analysis were 
mode of treatment, time after completion of treatment, ECOG 
performance status score, level of education, age, caregivers at 
home, and financial problem as presented in Table 2. The type 
of cancer, combination or single modality of the treatment 
and duration of treatment did not appear to be correlated 
with long-term QoL. 
All factors that had p<0.2 in univariate analysis were included 
in multivariate analysis. Factors found to have correlation with 
QoL scores in multivariate analysis were ECOG performance 
status, level of education, caregiver and presence/absence of 
economic problem as shown in Table 4.
DISCUSSION
 
Although the cancer patients reported higher age, divorced/
separated status and unemployment with lower educational 
level and performance status compared to the healthy group 
(Table 1), the mean overall FACT-G score in the gynecologic 
cancer patient group was significantly higher than that of the 
healthy group (82.15, SD=12.86 vs. 72.58, SD=13.80, p<0.001) 
Table 4. Results of multivariate logistic regression analysis for overall 
FACT-G scores
Variable No.
Standardized correlation 
coefficient
p-value* 
Correlation 
coefficient
95% CI of 
correlation 
coefficient
Caregiver      
  Husband  485 2.8 1.15–4.46 0.001
  Others  385
Financial problem    
  No 559 4.86 3.14–6.58 <0.001
  Yes 311
ECOG score      
  0 219 9.52  7.15–11.88 <0.001
  1 453 4.59 2.54 –6.63 <0.001
  2 198
Education    
  College 126 2.92 1.59–6.32 0.34
  High school 219 0.96 -1.02–2.95 0.02
 <High school  524
Chemotherapy    
  Yes 187 -2.5 -5.25–0.24    0.074
  No 683
Radiation
  Yes 510 -0.84 -3.23–1.54    0.488
  No 360
Surgery
  Yes 517 -0.14 -2.46–2.18    0.907
  No 535
Time after treatment (mo)    
   <24 177 1.55 -0.58–3.69    0.154
   24–36   97 1.45 -1.22–4.13    0.287
   37–48 100 1.09 -0.15–3.71    0.411
   49–60   59 -0.39 -3.67–2.87    0.811
   >60 437
Age (yr)    
   <40 507 1.26 -1.22–3.74    0.317
   40–60  117 -0.83 -3.73–2.05    0.569
   >60 246
FACT-G, Functional Assessment of Cancer Therapy-General; CI, 
confidence interval; ECOG, Eastern Cooperative Oncology Group.
*Spearman rank correlations.Sarikapan Wilailak, et al.
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(Table 2). The scores of each subscale measuring emotional, 
functional, social/family and physical well-being were also 
higher in the patient group than in the healthy group as 
shown in Table 2. This finding indicated that recovery from 
treatment for gynecological cancer has a positive effect 
upon QoL. Previous QoL studies compared cancer patients’ 
score and healthy participants were reviewed and shown in 
Table 5. Our study result corresponded well with them. The 
researcher agreed with Miller and Lutgendorf that patients 
with QoL impairment might have been able to adapt to their 
life circumstances by modifying their internal standards, 
values and their own conceptualization of QoL over time, 
a phenomenon called “response shift” [6,8,11]. Treatment 
modalities appeared to have some effect on quality of life. 
Patients who underwent radiation therapy had lower FACT-G 
scores after treatment, while patients who underwent 
surgery had higher FACT-G scores, especially in the physical 
subscores. Recovery after surgery was more rapid while the 
effect of radiation persisted; thus, this might explain their 
effect on the patients’ QoL. However, the results from other 
studies also varied [6-8,12-14]. And in our study, the mode of 
treatment did not correlate with QoL on multivariate analysis. 
The effect of treatment might explain why cervical cancer 
patients, who were treated mostly by radiation therapy alone, 
reported slightly lower QoL than patients with other types of 
gynecologic cancer in this study. However, the results were 
insignificant on univariate and multivariate analysis. The result 
was similar to other studies which reported that the site of 
disease had marginal impact on QoL during active treatment 
and no impact after completion of treatment [7,12]. 
Performance status significantly correlated with total FACT-G 
scores in both univariate and multivariate analyses. Poorer 
performance status correlated with lower scores in all aspects 
of well-being. The result was similar to the findings from 
Greimel et al. in which performance statuses were identified 
as significant predictors for QoL one year after treatment 
[13]. Patients in the 40-60 year old age group scored higher 
FACT-G scores than younger or older age groups. However, 
age did not correlate with QoL on multivariate analysis. Miller 
et al. [6] and Lai et al. [15] reported similar findings in the US 
and Hong Kong [6], while Chan et al. [7] found that age was 
one of the factors identified as having significant effect on 
long term QoL after treatment in Hong Kong. They found that 
younger patients had poorer QoL which might have resulted 
from unexpectedness of impaired fertility and femininity, 
treatment-related menopause and relationship issues.
Higher levels of education were also significantly related to 
higher QoL. The differences were evident in the functional 
and social well-being subscores. This was confirmed by 
multivariate analysis. Miller et al. [6] found that the most 
significant difference in QoL was seen among US patients who 
had not completed high school. Lower levels of education 
were associated with less supportive social environment, 
limited knowledge regarding health issues and poor health 
[16].
Economic problems and financial difficulties also significantly 
affected QoL from both univariate and multivariate analysis. 
Cella et al. [17] reported that patients with the poorest income 
and lowest educational level generally had lower performance 
status and significant survival disadvantage.
Univariate and multivariate analysis stressed the importance 
of having husbands as principal caregivers. Lai et al also found 
that older patients with cervical cancer who had a partner 
and possessed religious belief were positively correlated with 
QoL [15]. In Sudan, marital status, occupation, education of 
the patient and also education of caregivers were associated 
with higher QoL scores [10]. In Finland, high levels of partner 
support were associated with female cancer patients’ 
optimistic appraisals and both were predictors of better 
health-related QoL at 8 months follow-up [18].
In conclusion, the QoL scores were higher in gynecologic 
cancer patients after treatment. And the factors that 
associated with the higher score in the patient group are 
having the husband as a caregiver, no financial problem, 
ECOG score 0 or 1 and having high school or higher 
education. The researcher, therefore, might propose that 
Table 5. Previous QoL studies compared cancer patients’ score and healthy participants
Authors Questionnaire Interval after treatment Difference in QoL score between patients, and healthy participants
Miller et al. [6] FACT-G 6 mo No
Chan et al. [7] EORTC-QLQ Longitudinal Yes (patients > healthy)
Lutgendorf et al. [8] FACT-G 1 yr Yes (patients > healthy)
Tahmasebi et al. [9] EORTC-QLQ 3 mo Yes (patients > healthy) except physical well-being
Awadalla et al. [10] WHO QoL-bref 1 yr Yes (patients > healthy)
QoL, quality of life; FACT-G, Functional Assessment of Cancer Therapy-General; EORTC-QLQ, European Organisation for Research and Treatment 
of Cancer; QLQ, quality of life questionnaire; WHO, World Health Organization.Quality of life of gynecologic cancer patients
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patients who experienced bad situations from cancer and 
treatment before recovery might be more optimistic about 
their present situation. ECOG performance status, level of 
education, caregivers and economic problems were found to 
correlate with QoL score. Hence, enhancing the above factors 
could be beneficial in improving QoL in gynecologic cancer 
patients. The weakness of this study is that this is a cross-
sectional study of which the range of the time after treatment 
is quite wide. Longitudinal study of QoL would add more 
complete information.
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